世界の狭心症治療市場予測（～2028年）：抗血小板薬、β-アドレナリン遮断薬、カルシウム拮抗薬、短・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬

• 英文タイトル：Global Angina Pectoris Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8727 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

狭心症治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の狭心症治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 狭心症治療市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・抗血小板薬、β-アドレナリン遮断薬、カルシウム拮抗薬、短・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の狭心症治療市場の主要な市場プレーヤーは以下のとおりです。 ・Abbott Laboratories Inc.、Astra Zeneca plc、Bayer AG、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、Forest Laboratories Inc、Gilead Sciences, Inc、GlaxoSmithKline plc、Novartis AG、Pfizer Inc.、Sanofi SA 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、狭心症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な狭心症治療メーカーの企業概要、2019年～2022年までの狭心症治療の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な狭心症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別狭心症治療の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの狭心症治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での狭心症治療市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および狭心症治療の産業チェーンを掲載しています。 ・第13、14、15章では、狭心症治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories Inc.、Astra Zeneca plc、Bayer AG、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、Forest Laboratories Inc、Gilead Sciences, Inc、GlaxoSmithKline plc、Novartis AG、Pfizer Inc.、Sanofi SA ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：抗血小板薬、β-アドレナリン遮断薬、カルシウム拮抗薬、短・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬 ・用途別分析2017年-2028年：病院、クリニック、その他 ・狭心症治療の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・狭心症治療のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・狭心症治療のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・狭心症治療の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・狭心症治療の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Angina Pectoris Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Angina Pectoris Treatment market size is estimated to be worth US$ 7980.9 million in 2021 and is forecast to a readjusted size of USD 9002.9 million by 2028 with a CAGR of 1.7% during review period. Hospitals accounting for % of the Angina Pectoris Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antiplatelet Agents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Angina Pectoris Treatment include Abbott Laboratories Inc., Astra Zeneca plc, Bayer AG, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Angina Pectoris Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antiplatelet Agents
Beta-Adrenergic Blocking Agents
Calcium Channel Blockers
Short & Long – Acting Nitroglycerines
Angiotensin-Converting Enzyme (ACE) Inhibitors
Anti-Ischemic Agents
Market segment by Application can be divided into
Hospitals
Clinic
Other
The key market players for global Angina Pectoris Treatment market are listed below:
Abbott Laboratories Inc.
Astra Zeneca plc
Bayer AG
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Forest Laboratories Inc
Gilead Sciences, Inc
GlaxoSmithKline plc
Novartis AG
Pfizer Inc.
Sanofi SA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angina Pectoris Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angina Pectoris Treatment, with price, sales, revenue and global market share of Angina Pectoris Treatment from 2019 to 2022.
Chapter 3, the Angina Pectoris Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angina Pectoris Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Angina Pectoris Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Angina Pectoris Treatment.
Chapter 13, 14, and 15, to describe Angina Pectoris Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Angina Pectoris Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angina Pectoris Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antiplatelet Agents
1.2.3 Beta-Adrenergic Blocking Agents
1.2.4 Calcium Channel Blockers
1.2.5 Short & Long – Acting Nitroglycerines
1.2.6 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.2.7 Anti-Ischemic Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Angina Pectoris Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Angina Pectoris Treatment Market Size & Forecast
1.4.1 Global Angina Pectoris Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Angina Pectoris Treatment Sales in Volume (2017-2028)
1.4.3 Global Angina Pectoris Treatment Price (2017-2028)
1.5 Global Angina Pectoris Treatment Production Capacity Analysis
1.5.1 Global Angina Pectoris Treatment Total Production Capacity (2017-2028)
1.5.2 Global Angina Pectoris Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angina Pectoris Treatment Market Drivers
1.6.2 Angina Pectoris Treatment Market Restraints
1.6.3 Angina Pectoris Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories Inc.
2.1.1 Abbott Laboratories Inc. Details
2.1.2 Abbott Laboratories Inc. Major Business
2.1.3 Abbott Laboratories Inc. Angina Pectoris Treatment Product and Services
2.1.4 Abbott Laboratories Inc. Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Astra Zeneca plc
2.2.1 Astra Zeneca plc Details
2.2.2 Astra Zeneca plc Major Business
2.2.3 Astra Zeneca plc Angina Pectoris Treatment Product and Services
2.2.4 Astra Zeneca plc Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Angina Pectoris Treatment Product and Services
2.3.4 Bayer AG Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Angina Pectoris Treatment Product and Services
2.4.4 Bristol-Myers Squibb Company Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business
2.5.3 F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Product and Services
2.5.4 F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Forest Laboratories Inc
2.6.1 Forest Laboratories Inc Details
2.6.2 Forest Laboratories Inc Major Business
2.6.3 Forest Laboratories Inc Angina Pectoris Treatment Product and Services
2.6.4 Forest Laboratories Inc Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gilead Sciences, Inc
2.7.1 Gilead Sciences, Inc Details
2.7.2 Gilead Sciences, Inc Major Business
2.7.3 Gilead Sciences, Inc Angina Pectoris Treatment Product and Services
2.7.4 Gilead Sciences, Inc Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business
2.8.3 GlaxoSmithKline plc Angina Pectoris Treatment Product and Services
2.8.4 GlaxoSmithKline plc Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Angina Pectoris Treatment Product and Services
2.9.4 Novartis AG Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer Inc.
2.10.1 Pfizer Inc. Details
2.10.2 Pfizer Inc. Major Business
2.10.3 Pfizer Inc. Angina Pectoris Treatment Product and Services
2.10.4 Pfizer Inc. Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sanofi SA
2.11.1 Sanofi SA Details
2.11.2 Sanofi SA Major Business
2.11.3 Sanofi SA Angina Pectoris Treatment Product and Services
2.11.4 Sanofi SA Angina Pectoris Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Angina Pectoris Treatment Breakdown Data by Manufacturer
3.1 Global Angina Pectoris Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Angina Pectoris Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Angina Pectoris Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Angina Pectoris Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Angina Pectoris Treatment Manufacturer Market Share in 2021
3.5 Global Angina Pectoris Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Angina Pectoris Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Angina Pectoris Treatment Market Size by Region
4.1.1 Global Angina Pectoris Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Angina Pectoris Treatment Revenue by Region (2017-2028)
4.2 North America Angina Pectoris Treatment Revenue (2017-2028)
4.3 Europe Angina Pectoris Treatment Revenue (2017-2028)
4.4 Asia-Pacific Angina Pectoris Treatment Revenue (2017-2028)
4.5 South America Angina Pectoris Treatment Revenue (2017-2028)
4.6 Middle East and Africa Angina Pectoris Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Angina Pectoris Treatment Sales in Volume by Type (2017-2028)
5.2 Global Angina Pectoris Treatment Revenue by Type (2017-2028)
5.3 Global Angina Pectoris Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Angina Pectoris Treatment Sales in Volume by Application (2017-2028)
6.2 Global Angina Pectoris Treatment Revenue by Application (2017-2028)
6.3 Global Angina Pectoris Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Angina Pectoris Treatment Sales by Type (2017-2028)
7.2 North America Angina Pectoris Treatment Sales by Application (2017-2028)
7.3 North America Angina Pectoris Treatment Market Size by Country
7.3.1 North America Angina Pectoris Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Angina Pectoris Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Angina Pectoris Treatment Sales by Type (2017-2028)
8.2 Europe Angina Pectoris Treatment Sales by Application (2017-2028)
8.3 Europe Angina Pectoris Treatment Market Size by Country
8.3.1 Europe Angina Pectoris Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Angina Pectoris Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Angina Pectoris Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Angina Pectoris Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Angina Pectoris Treatment Market Size by Region
9.3.1 Asia-Pacific Angina Pectoris Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Angina Pectoris Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Angina Pectoris Treatment Sales by Type (2017-2028)
10.2 South America Angina Pectoris Treatment Sales by Application (2017-2028)
10.3 South America Angina Pectoris Treatment Market Size by Country
10.3.1 South America Angina Pectoris Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Angina Pectoris Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angina Pectoris Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Angina Pectoris Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Angina Pectoris Treatment Market Size by Country
11.3.1 Middle East & Africa Angina Pectoris Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Angina Pectoris Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Angina Pectoris Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Angina Pectoris Treatment
12.3 Angina Pectoris Treatment Production Process
12.4 Angina Pectoris Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Angina Pectoris Treatment Typical Distributors
13.3 Angina Pectoris Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---